Energesis Pharmaceuticals Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.49M
Latest Deal Amount
  • Investors
  • 4

Energesis Pharmaceuticals General Information

Description

Provider of drug development and discovery services for obesity and diabetes. The company develops and formulates drugs and other formulations for the treatment of obesity, diabetes and other related metabolic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • One Kendall Square
  • Building 200, Suite 2203
  • Cambridge, MA 02139
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Energesis Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 26-May-2015 $1.49M 0000 Completed Startup
1. Accelerator/Incubator 21-Oct-2010 0000 0000 Completed Startup
To view Energesis Pharmaceuticals’s complete valuation and funding history, request access »

Energesis Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Brian Freeman MD Co-Founder & Chief Operating Officer
Olivier Boss Ph.D Co-Founder & Chief Scientific Officer
Jean-Paul Giacobino Ph.D Co-Founder
To view Energesis Pharmaceuticals’s complete executive team members history, request access »

Energesis Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Massachusetts Life Sciences Center Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
MassChallenge Accelerator/Incubator 000 0000 000000 0
To view Energesis Pharmaceuticals’s complete investors history, request access »